Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
20/03/202100:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
19/03/202123:40PR Newswire (US)Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 VaccinesNASDAQ:ORMPOramed Pharmaceuticals Inc
19/03/202123:40PR Newswire (US)Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 VaccinesNASDAQ:ORMPOramed Pharmaceuticals Inc
16/03/202123:25PR Newswire (US)Oramed Reaches 25% Randomization in World's First Phase 3 Oral Insulin Study Conducted Under FDA Approved ProtocolNASDAQ:ORMPOramed Pharmaceuticals Inc
05/03/202100:25PR Newswire (US)Oramed to Present at H.C. Wainwright Global Life Sciences Conference 2021NASDAQ:ORMPOramed Pharmaceuticals Inc
03/03/202108:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
18/02/202108:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
11/02/202122:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ORMPOramed Pharmaceuticals Inc
10/02/202107:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/02/202109:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/02/202109:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/02/202109:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
09/02/202109:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORMPOramed Pharmaceuticals Inc
05/02/202108:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
04/02/202109:21Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ORMPOramed Pharmaceuticals Inc
28/01/202101:00PR Newswire (US)Oramed Issues Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
22/01/202100:25PR Newswire (US)Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin StudyNASDAQ:ORMPOramed Pharmaceuticals Inc
15/01/202108:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORMPOramed Pharmaceuticals Inc
08/01/202100:40PR Newswire (US)Oramed to Present at H.C. Wainwright BioConnect 2021 ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
24/12/202000:25PR Newswire (US)Oramed Reports Positive First in Human Data from Oral Leptin StudyNASDAQ:ORMPOramed Pharmaceuticals Inc
03/12/202000:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
03/12/202000:25PR Newswire (US)Oramed Initiates Phase 2 NASH Trial of Oral InsulinNASDAQ:ORMPOramed Pharmaceuticals Inc
02/12/202009:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
25/11/202000:10PR Newswire (US)Oramed Initiates Phase 3 Trial of Oral InsulinNASDAQ:ORMPOramed Pharmaceuticals Inc
24/11/202023:38Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
13/11/202000:40PR Newswire (US)Nobel Laureate, Oramed SAB member Prof. Avram Hershko and Oramed CSO Dr. Miriam Kidron to be Featured on Biotalknology Webina...NASDAQ:ORMPOramed Pharmaceuticals Inc
11/11/202000:25PR Newswire (US)Oramed to Present at H.C. Wainwright 6th Annual Israel ConferenceNASDAQ:ORMPOramed Pharmaceuticals Inc
28/10/202023:40PR Newswire (US)Oramed to Present Phase 2b Oral Insulin Data at American Association of Pharmaceutical Scientists 2020 PharmSci 360 Conferenc...NASDAQ:ORMPOramed Pharmaceuticals Inc
27/10/202023:55PR Newswire (US)Oramed CEO Nadav Kidron & Premas Biotech to Host Webinar "The Journey of Oral Insulin: Oramed Story" on Wednesday October 28,...NASDAQ:ORMPOramed Pharmaceuticals Inc
23/10/202007:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP